266 related articles for article (PubMed ID: 19836794)
1. Upper urinary tract recurrence after radical cystectomy for bladder cancer--who is at risk?
Volkmer BG; Schnoeller T; Kuefer R; Gust K; Finter F; Hautmann RE
J Urol; 2009 Dec; 182(6):2632-7. PubMed ID: 19836794
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors Analysis and Pathogen Distribution of Urinary Tract Infection in Patients Undergoing Cutaneous Ureterostomy After Radical Cystectomy for Bladder Cancer.
Zhu MR; Hong HX; Cheng JR; Tang J; Lu T; Xie R
Biol Res Nurs; 2024 Jul; 26(3):361-367. PubMed ID: 38196248
[TBL] [Abstract][Full Text] [Related]
3. Cumulative incidence and risk factors for recurrence of upper tract urothelial carcinoma in patients undergoing radical cystectomy.
Yamashita R; Nakamura M; Notsu A; Asakura K; Usui K; Sakura Y; Shinsaka H; Matsuzaki M; Sugino T; Mizuno R; Niwakawa M; Oya M
BJUI Compass; 2024 May; 5(5):483-489. PubMed ID: 38751952
[TBL] [Abstract][Full Text] [Related]
4. Routine Surveillance of Upper Urinary Tract Imaging for Diagnosing Upper Urinary Tract Urothelial Cancer Recurrence in Patients with Nonmuscle Invasive Bladder Cancer.
Nishimura N; Miyake M; Miyamoto T; Shimizu T; Fujii T; Morizawa Y; Hori S; Gotoh D; Nakai Y; Torimoto K; Tanaka N; Fujimoto K
Adv Urol; 2024; 2024():5894288. PubMed ID: 38807901
[TBL] [Abstract][Full Text] [Related]
5. Focus on Upper Urinary Tract Stones Combined with Parenchymal Infiltrative Renal Pelvis Cancer.
Zhang Y; Ke Y; Qiu AX; Yang B; Shen C; Wen LJ; Xu XL; Yu Y; Wang W
Kidney Blood Press Res; 2024; 49(1):228-238. PubMed ID: 38471493
[TBL] [Abstract][Full Text] [Related]
6. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
[TBL] [Abstract][Full Text] [Related]
7. Ureteral carcinoma in situ at radical cystectomy: does the margin matter?
Silver DA; Stroumbakis N; Russo P; Fair WR; Herr HW
J Urol; 1997 Sep; 158(3 Pt 1):768-71. PubMed ID: 9258077
[TBL] [Abstract][Full Text] [Related]
8. CT Evaluation of the Findings of Nutcracker Syndrome in Patients with Bladder Cancer after Radical Cystectomy and Ileal Neobladder Formation: A Correlation with Hematuria.
Shin HM; Lee J; Lee DH; Kim SH
J Korean Soc Radiol; 2023 Mar; 84(2):409-417. PubMed ID: 37051384
[TBL] [Abstract][Full Text] [Related]
9. Subsequent Upper Urinary Tract Carcinoma Related to Worse Survival in Patients Treated with BCG.
Numakura K; Miyake M; Kobayashi M; Muto Y; Sekine Y; Nishimura N; Iida K; Shiga M; Morizane S; Yoneyama T; Matsumura Y; Abe T; Yamada T; Matsumoto K; Inokuchi J; Nishiyama N; Taoka R; Kobayashi T; Kojima T; Kitamura H; Nishiyama H; Fujimoto K; Habuchi T
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046663
[TBL] [Abstract][Full Text] [Related]
10. Prognostic values of distal ureter involvement and survival outcomes in bladder cancer at T1 and T2 stages: a propensity score matching study.
Xiao S; Zhan X; Chen T; Wu J; Xu L; Jiang M; Deng W; Zhu K; Zeng Z; Cheng X; Zhou Q; Huang W; Zhou X; Zhang C; Fu B; Wang G
Int Urol Nephrol; 2022 Dec; 54(12):3123-3137. PubMed ID: 35962905
[TBL] [Abstract][Full Text] [Related]
11. Can frozen-section analysis of ureteric margins at the time of radical cystectomy predict upper tract recurrence?
Soliman K; Taha DE; Aboumarzouk OM; Koraiem IO; Shokeir AA
Arab J Urol; 2020 Apr; 18(3):155-162. PubMed ID: 33029425
[TBL] [Abstract][Full Text] [Related]
12. Impact of double J stenting or nephrostomy placement during transurethral resection of bladder tumour on the incidence of metachronous upper urinary tract urothelial cancer.
Hupe MC; Dormayer L; Ozimek T; Struck JP; Hennig MJP; Klee M; von Klot CAJ; Kuczyk MA; Merseburger AS; Kramer MW
BMC Cancer; 2020 Feb; 20(1):140. PubMed ID: 32085750
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for upper tract urothelial recurrence following local excision of bladder cancer.
Lin N; Wu YP; Lin YZ; Tao X; Chen SH; Ke ZB; Wei Y; Zheng QS; Xue XY; Xu N
Cancer Med; 2018 Aug; 7(8):4098-4103. PubMed ID: 29953747
[TBL] [Abstract][Full Text] [Related]
14. Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomy.
Vasdev N; Zargar H; Noël JP; Veeratterapillay R; Fairey AS; Mertens LS; Dinney CP; Mir MC; Krabbe LM; Cookson MS; Jacobsen NE; Gandhi NM; Griffin J; Montgomery JS; Yu EY; Xylinas E; Campain NJ; Kassouf W; Dall'Era MA; Seah JA; Ercole CE; Horenblas S; Sridhar SS; McGrath JS; Aning J; Shariat SF; Wright JL; Morgan TM; Bivalacqua TJ; North S; Barocas DA; Lotan Y; Grivas P; Stephenson AJ; Shah JB; van Rhijn BW; Daneshmand S; Spiess PE; Holzbeierlein JM; Thorpe A; Black PC
World J Urol; 2019 Jan; 37(1):165-172. PubMed ID: 29882105
[TBL] [Abstract][Full Text] [Related]
15. Risk-stratified surveillance protocol improves cost-effectiveness after radical nephroureterectomy in patients with upper tract urothelial carcinoma.
Momota M; Hatakeyama S; Yamamoto H; Iwamura H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Iwabuchi I; Ogasawara M; Kawaguchi T; Ohyama C
Oncotarget; 2018 May; 9(33):23047-23057. PubMed ID: 29796171
[TBL] [Abstract][Full Text] [Related]
16. Asymptomatic recurrence detection and cost-effectiveness in urothelial carcinoma.
Iwamura H; Hatakeyama S; Sato M; Ohyama C
Med Oncol; 2018 May; 35(6):94. PubMed ID: 29744601
[TBL] [Abstract][Full Text] [Related]
17. Detecting asymptomatic recurrence after radical nephroureterectomy contributes to better prognosis in patients with upper urinary tract urothelial carcinoma.
Horiguchi H; Hatakeyama S; Anan G; Kubota Y; Kodama H; Momota M; Kido K; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Ito H; Yoshikawa K; Kawaguchi T; Sato M; Ohyama C
Oncotarget; 2018 Feb; 9(9):8746-8755. PubMed ID: 29492234
[TBL] [Abstract][Full Text] [Related]
18. Double J stent prior to cystectomy increases the risk of upper urinary tract recurrence?
Gupta R; Gupta S; Basu S
Transl Androl Urol; 2017 Dec; 6(6):1203-1204. PubMed ID: 29354513
[No Abstract] [Full Text] [Related]
19. Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer.
Kusaka A; Hatakeyama S; Hosogoe S; Hamano I; Iwamura H; Fujita N; Fukushi K; Narita T; Hagiwara K; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Ito H; Yoshikawa K; Kawaguchi T; Ohyama C
Oncotarget; 2017 Sep; 8(39):65492-65505. PubMed ID: 29029448
[TBL] [Abstract][Full Text] [Related]
20. Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer.
Kusaka A; Hatakeyama S; Hosogoe S; Hamano I; Iwamura H; Fujita N; Fukushi K; Narita T; Yamamoto H; Tobisawa Y; Yoneyama T; Yoneyama T; Hashimoto Y; Koie T; Ito H; Yoshikawa K; Kawaguchi T; Ohyama C
Med Oncol; 2017 May; 34(5):90. PubMed ID: 28397105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
